Wednesday, 11 May 2016

Diabetes Asia Pacific 2018

About Conference

Being perceived as an incredibly Reputed Organization, Conference Series LLC invites  the worldwide global audience and presenters to participate at the 20th Asia Pacific Diabetes Conference which is to be held in Sydney, Australia during July 16-17, 2018. Special interest and theme of the conference is “Therapeutic Approaches for Diabetes Management and endocrine complications”.

Diabetes is a disease that affects your body's ability to produce or use insulin. Insulin is a hormone. When your body turns the food you eat into energy (also called sugar or glucose), insulin is released to help transport this energy to the cells. Insulin acts as a “key.” Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both.

Diabetes Asia Pacific 2018 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Asia Pacific 2018 is where the future of management and novel therapeutics for the disease intersects.

The Annual conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. The meeting gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

The drugs market in field of internal Medicine especially in diabetes and Endocrinology in America is expected to reach USD 41 billion by 2020, growing at a CAGR of over 6%.The drugs market in EMEA will exceed USD 16 billion by 2020, growing at a CAGR of over 6%. The drugs market in APAC is expected to exceed USD 14 billion by 2020, growing at a CAGR of over 7%. Key suppliers are Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca, and AbbVie       

Conference Series Ltd organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members

Why to attend?

Diabetes Asia Pacific 2018 highlights the theme “Therapeutic Approaches for Diabetes Management and endocrine complications” Which emphasis on the latest advancements in prevention and treatment cure of various metabolic diseases which may be due to diabetic and endocrine complications and provides robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Endocrine Complications.. 

Target Audience:

  • Endocrinologists
  • Diabetologists
  • Researchers
  • Practitioners/Doctors
  • Students
  • Nurse educator
  • Podiatrist
  • Dietitian
  • Eye Doctors
  • Nephrologists
  • Physical trainer or Exercise physiologist

Conference Highlights

Special Issues

  •  All accepted abstracts will be published in respective Supporting International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: